연구성과로 돌아가기
JCR 2023 저널 목록 (564 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal of Family and Economic Issues | SPRINGER INT PUBL AG | 1058-0476 | 1573-3475 | SSCI | ECONOMICS | 1,976 | 2.3 | Q2 | 29.1 | 70.9 | 175/600 | 2.8 | Q2 | 2.1 | 0.3 | 0.85 | 167/603 | Q2 | 72.39 | 0.002 | 0.435 | 0.742 | Q2 | 56 | 100.0% | 7.0 | 9.4 | 56 | 22.9% | 2025-03-24 17:04:56 | 바로가기 |
| Journal of Health Economics and Outcomes Research | COLUMBIA DATA ANALYTICS, LLC | 2327-2236 | 2327-2236 | ESCI | ECONOMICS | 242 | 2.3 | Q2 | 29.1 | 70.9 | 175/600 | N/A | N/A | 2.3 | 0.2 | 0.79 | 184/603 | Q2 | 69.57 | 0.001 | 0.124 | N/A | N/A | 31 | 96.8% | 2.6 | 6.1 | 30 | 97.8% | 2025-03-24 17:05:25 | 바로가기 |
| JOURNAL OF NEURAL TRANSMISSION | SPRINGER WIEN | 0300-9564 | 1435-1463 | SCIE | CLINICAL NEUROLOGY | 8,619 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.7 | Q2 | 3.0 | 0.9 | 0.77 | 120/281 | Q2 | 57.47 | 0.006 | 1.252 | 0.948 | Q2 | 135 | 60.7% | 8.9 | 7.9 | 82 | 52.4% | 2025-03-24 17:00:23 | 바로가기 |
| JOURNAL OF NEURO-ONCOLOGY | SPRINGER | 0167-594X | 1573-7373 | SCIE | CLINICAL NEUROLOGY | 14,916 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.7 | Q2 | 3.0 | 0.8 | 0.84 | 100/281 | Q2 | 64.59 | 0.014 | 3.040 | 1.139 | Q2 | 272 | 82.4% | 7.7 | 6.8 | 224 | 24.4% | 2025-03-24 17:00:20 | 바로가기 |
| Journal of Neuromuscular Diseases | IOS PRESS | 2214-3599 | 2214-3602 | SCIE | CLINICAL NEUROLOGY | 1,511 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | N/A | N/A | 3.0 | 0.9 | 0.78 | 115/281 | Q2 | 59.25 | 0.003 | 0.638 | N/A | N/A | 88 | 80.7% | 3.9 | 7.3 | 71 | 53.4% | 2025-03-24 17:00:37 | 바로가기 |
| JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | OXFORD UNIV PRESS INC | 0022-3069 | 1554-6578 | SCIE | CLINICAL NEUROLOGY | 9,179 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.1 | Q2 | 2.9 | 0.8 | 0.84 | 100/281 | Q2 | 64.59 | 0.005 | 1.011 | 1.075 | Q2 | 66 | 90.9% | 14.3 | 6.9 | 60 | 24.0% | 2025-03-24 17:00:22 | 바로가기 |
| JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | ELSEVIER SCIENCE INC | 0885-3924 | 1873-6513 | SCIE | CLINICAL NEUROLOGY | 14,601 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.8 | Q2 | 3.0 | 1.0 | 1.30 | 41/281 | Q1 | 85.59 | 0.015 | 3.328 | 1.327 | Q1 | 180 | 83.9% | 7.9 | 7.1 | 151 | 13.1% | 2025-03-24 17:00:20 | 바로가기 |
| JOURNAL OF PRODUCTIVITY ANALYSIS | SPRINGER | 0895-562X | 1573-0441 | SSCI | ECONOMICS | 2,888 | 2.3 | Q2 | 29.1 | 70.9 | 175/600 | 2.5 | Q2 | 1.9 | 0.3 | 0.63 | 237/603 | Q2 | 60.78 | 0.001 | 0.149 | 0.638 | Q2 | 55 | 96.4% | 15.3 | 13.3 | 53 | 31.0% | 2025-03-24 17:04:52 | 바로가기 |
| MIT SLOAN MANAGEMENT REVIEW | SLOAN MANAGEMENT REVIEW ASSOC, MIT SLOAN SCHOOL MANAGEMENT | 1532-9194 | 1532-8937 | SSCI | MANAGEMENT | 3,974 | 4.0 | Q2 | 29.1 | 70.9 | 119/407 | 4.5 | Q2 | 3.8 | 0.9 | 0.32 | 307/407 | Q4 | 24.69 | 0.003 | 0.596 | 1.688 | Q1 | 31 | 100.0% | 10.2 | 6.1 | 31 | 0.0% | 2025-03-24 17:24:51 | 바로가기 |
| MOLECULAR DIVERSITY | SPRINGER | 1381-1991 | 1573-501X | SCIE | CHEMISTRY, APPLIED | 3,995 | 3.9 | Q2 | 29.1 | 70.9 | 22/74 | 3.5 | Q2 | 3.8 | 1.0 | 0.73 | 23/74 | Q2 | 69.59 | 0.003 | 0.697 | 0.485 | Q2 | 175 | 88.0% | 3.2 | 7.3 | 154 | 8.4% | 2025-03-24 16:59:03 | 바로가기 |
| NEUROEPIDEMIOLOGY | KARGER | 0251-5350 | 1423-0208 | SCIE | CLINICAL NEUROLOGY | 4,287 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 4.3 | Q1 | 3.1 | 0.4 | 1.09 | 65/281 | Q1 | 77.05 | 0.003 | 0.655 | 1.344 | Q1 | 37 | 86.5% | 10.1 | 7.5 | 32 | 28.1% | 2025-03-24 17:00:28 | 바로가기 |
| Neurology International | MDPI | 2035-8377 | 2035-8377 | ESCI | CLINICAL NEUROLOGY | 781 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 2.6 | Q3 | 3.0 | 0.8 | 0.85 | 97/281 | Q2 | 65.66 | 0.001 | 0.235 | 0.624 | Q3 | 94 | 58.5% | 2.4 | 6.7 | 55 | 99.2% | 2025-03-24 17:00:41 | 바로가기 |
| NEUROMODULATION | ELSEVIER | 1094-7159 | 1525-1403 | SCIE | CLINICAL NEUROLOGY | 4,926 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.5 | Q2 | 2.8 | 1.7 | 0.75 | 128/281 | Q2 | 54.63 | 0.006 | 1.237 | 1.000 | Q2 | 174 | 86.2% | 5.4 | 8.8 | 150 | 26.1% | 2025-03-24 17:00:27 | 바로가기 |
| npj Aging | NATURE PUBL GROUP | N/A | 2731-6068 | ESCI | GERIATRICS & GERONTOLOGY | 86 | 4.1 | Q2 | 29.1 | 70.9 | 22/74 | 4.1 | Q2 | 4.1 | 1.0 | 1.46 | 9/74 | Q1 | 88.51 | 0.000 | 0.031 | 1.139 | Q2 | 26 | 84.6% | N/A | 8.0 | 22 | 100.0% | 2025-03-24 17:16:46 | 바로가기 |
| PEDIATRIC NEUROLOGY | ELSEVIER SCIENCE INC | 0887-8994 | 1873-5150 | SCIE | CLINICAL NEUROLOGY | 6,410 | 3.2 | Q2 | 29.1 | 70.9 | 82/280 | 3.3 | Q2 | 3.0 | 0.3 | 1.01 | 73/281 | Q2 | 74.20 | 0.006 | 1.287 | 1.097 | Q2 | 237 | 85.6% | 8.7 | 8.0 | 203 | 14.1% | 2025-03-24 17:00:25 | 바로가기 |
페이지 이동: